Multicentric, Open label, Randomized, Parallel-group, Active-controlled Clinical trial of the Fixed Dose Combination of Glucosamine 750 mg, Diacerein 50 mg and Aceclofenac 100 mg In patients with osteoarthritis of knee joint.

Trial Profile

Multicentric, Open label, Randomized, Parallel-group, Active-controlled Clinical trial of the Fixed Dose Combination of Glucosamine 750 mg, Diacerein 50 mg and Aceclofenac 100 mg In patients with osteoarthritis of knee joint.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Aceclofenac/diacerein; Aceclofenac/diacerein/glucosamine
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Jenburkt Pharmaceuticals
  • Most Recent Events

    • 10 Jul 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 17 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top